Postby skb » Mon Mar 31, 2025 9:02 am
Here is some more detailed information.
https://finance.yahoo.com/news/inside-f ... 56824.htmlCell Therapy refers to a technique in which the patient's own white blood cells are modified to fight cancer. We might have heard about it in CAR-T cell therapy.
Making customized medicines for millions of individual cancer patients is hard. We have a scaling problem.
Cellares will manufacture such personalized drugs for Bristol Squibb Myers at a large scale.
The article talks ONLY ABOUT BLOOD CANCER therapy drug, not COLORECTAL
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm, Avastin + Xeloda